← Eichor
Study identifier: NCT02138695 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Evaluation for Prognostic Factors After Catheter Ablation of Atrial Fibrillation: Cohort Study

Condition: Atrial Fibrillation  ·  Sponsor: Yonsei University

PhaseN/A
Planned participants3100
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

1\. Purpose of the study 1\) To explore clinical recurrence associated clinical factors including age, sex, clinical, electrophysiological, anatomical, imaging, and serologic characteristics. 2\) To develop simulation model to predict clinical recurrence and the efficacy of catheter ablation 2. Scientific evidence of the study 1. In atrial fibrillation patients, the maintenance of normal sinus rhythm showed significant reduction of mortality. 2. drug therapy with anti-arrhythmic drug showed many complications and side effect, thus non-drug therapy such as catheter ablation is developed. 3. catheter ablation has been performed for 10years world-wide, and showed superior treatment outcome compared with drug therapy. 4. clinical outcome after catheter ablation is affected not only by age, sex and underlying disease, but also by electrophysiologic, imaging, serologic and electroanatomical remodeling of the heart. However, there are few studies concerning these multifactorial variables. 3\. Study population

This description comes directly from the study's public registry record.

Talk to the study team

Hui-Nam Pak, MD  ·  82-2-2228-8459  ·  hnpak@yuhs.ac

Always discuss trial participation with your own doctor first.

Locations (1)

Severance HospitalSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02138695